AtaiBeckley shares surge amid reported acquisition talks with Eli Lilly
Shares of AtaiBeckley surged over 50% premarket after reports indicated that Eli Lilly was in advanced negotiations to acquire the psychedelic drug developer. The potential deal, which could exceed $2 billion, has sparked a broader rally across the sector as investors anticipate increased interest and capital inflow following U.S. President Donald Trump's executive order on psychedelics.
Tickers: $ATAI $CMPS $ENIC $ENVB $GHRS $LLY
Topics: Pharmaceuticals Psychedelic drugs Stock market reaction